Cargando…
Cytokine Modulators in Plaque Psoriasis – A Review of Current and Prospective Biologic Therapeutic Approaches
Psoriasis is a debilitating inflammatory condition that affects physiological and psychological states of millions around the world. Conventional biologic and nonbiologic therapies are fraught with profound adverse side effect profiles, frequent injection requirements, suboptimal outcomes, and other...
Autores principales: | Strychalski, Marisa L., Brown, Henry S., Bishop, Stephanie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558046/ https://www.ncbi.nlm.nih.gov/pubmed/36248203 http://dx.doi.org/10.1016/j.jdin.2022.08.008 |
Ejemplares similares
-
Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis
por: Pan, Ran, et al.
Publicado: (2022) -
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials
por: Wang, Yuqian, et al.
Publicado: (2023) -
Efficacy and safety of tofacitinib for the treatment of chronic plaque psoriasis: a systematic review and meta-analysis
por: Tian, Fangyuan, et al.
Publicado: (2019) -
Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis
por: Bai, Fan, et al.
Publicado: (2017) -
Association between metabolic syndrome and psoriasis: a meta-analysis of observational studies with non-psoriasis control groups
por: Qiao, Ju, et al.
Publicado: (2020)